Your browser doesn't support javascript.
loading
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma.
Nastoupil, Loretta J; Hess, Georg; Pavlovsky, Miguel A; Danielewicz, Iwona; Freeman, Jane; García-Sancho, Alejandro Martin; Glazunova, Valeria; Grigg, Andrew; Hou, Jing-Zhou; Janssens, Ann; Kim, Seok Jin; Masliak, Zvenyslava; McKay, Pam; Merli, Francesco; Munakata, Wataru; Nagai, Hirokazu; Özcan, Muhit; Preis, Meir; Wang, Tingyu; Rowe, Melissa; Tamegnon, Monelle; Qin, Rui; Henninger, Todd; Curtis, Madeliene; Caces, Donne Bennett; Thieblemont, Catherine; Salles, Gilles.
Afiliação
  • Nastoupil LJ; Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hess G; Hematology Department, Johannes Gutenberg-Universität Mainz, Mainz, Germany.
  • Pavlovsky MA; Department of Hematology, Fundaleu, Buenos Aires, Argentina.
  • Danielewicz I; Department of Clinical Oncology, Maritime Hospital in Gdynia, Gdynia, Poland.
  • Freeman J; Northern Haematology and Oncology Arm, Sydney Adventist Hospital, Sydney, NSW, Australia.
  • García-Sancho AM; Department of Hematology, Hospital Universitario de Salamanca, Centro de Investigación Biomédica en Red Cáncer, Centro de Investigación del Cáncer de Salamanca-Instituto Universitario de Biología Molecular y Celular del Cáncer, Salamanca, Spain.
  • Glazunova V; SP Botkin City Clinical Hospital, Moscow, Russia.
  • Grigg A; Department of Clinical Haematology, Austin Hospital, Melbourne, VIC, Australia.
  • Hou JZ; University of Pittsburgh Medical Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.
  • Janssens A; Department of Hematology, Universitair Ziekenhuis Leuven, Leuven, Belgium.
  • Kim SJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Masliak Z; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine.
  • McKay P; The Beatson West of Scotland Cancer Centre, Glasgow, Scotland.
  • Merli F; Hematology, Azienda Unità Sanitaria Locale - Istituti di Ricovero e Cura a Carattere Scientifico di Reggio Emilia, Reggio Emilia, Italy.
  • Munakata W; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Özcan M; Department of Hematology, Ankara University School of Medicine, Ankara, Turkey.
  • Preis M; Institute of Hematology, Lady Davis Carmel Medical Center, Haifa, Israel.
  • Wang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
  • Rowe M; Tianjin Institutes of Health Science, Tianjin, China.
  • Tamegnon M; Janssen Research & Development, High Wycombe, United Kingdom.
  • Qin R; Janssen Research & Development, Raritan, NJ.
  • Henninger T; Janssen Research & Development, Raritan, NJ.
  • Curtis M; Janssen Research & Development, Raritan, NJ.
  • Caces DB; Janssen Research & Development, High Wycombe, United Kingdom.
  • Thieblemont C; Janssen Research & Development, Raritan, NJ.
  • Salles G; Hemato-Oncology Department, Hôpital Saint-Louis, Paris, France.
Blood Adv ; 7(22): 7141-7150, 2023 11 28.
Article em En | MEDLINE | ID: mdl-37722354
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma de Zona Marginal Tipo Células B Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma de Zona Marginal Tipo Células B Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos